Revenue Summary of SCI Pharmtech, Inc.

SCI Pharmtech, Inc.'s latest annual revenue in 2023 was 1.2 Billion TWD , up 33.83% from previous year.
SCI Pharmtech, Inc.'s latest quarterly revenue in 2024 Q2 was 392.71 Million TWD , up 26.73% from previous quarter.
SCI Pharmtech, Inc. reported a annual revenue of 899.73 Million TWD in annual revenue 2022, up 4.11% from previous year.
SCI Pharmtech, Inc. reported a annual revenue of 864.21 Million TWD in annual revenue 2021, down -67.86% from previous year.
SCI Pharmtech, Inc. reported a quarterly revenue of 309.87 Million TWD for 2024 Q1, up 6.34% from previous quarter.
SCI Pharmtech, Inc. reported a quarterly revenue of 257.84 Million TWD for 2023 Q3, down -17.65% from previous quarter.

Annual Revenue Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Revenue of SCI Pharmtech, Inc. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	1.2 Billion TWD	33.83%
2022	899.73 Million TWD	4.11%
2021	864.21 Million TWD	-67.86%
2020	2.68 Billion TWD	14.16%
2019	2.35 Billion TWD	21.44%
2018	1.93 Billion TWD	49.1%
2017	1.3 Billion TWD	-31.64%
2016	1.9 Billion TWD	5.11%
2015	1.81 Billion TWD	21.36%
2014	1.49 Billion TWD	15.4%
2013	1.29 Billion TWD	2.39%
2012	1.26 Billion TWD	21.65%
2011	1.03 Billion TWD	4.34%
2010	994.67 Million TWD	9.82%
2009	905.73 Million TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	392.71 Million TWD	26.73%
2024 Q1	309.87 Million TWD	6.34%
2023 Q3	257.84 Million TWD	-17.65%
2023 Q4	291.41 Million TWD	13.02%
2023 Q1	341.77 Million TWD	51.39%
2023 Q2	313.11 Million TWD	-8.39%
2023 FY	1.2 Billion TWD	33.83%
2022 Q2	181.36 Million TWD	-3.54%
2022 FY	899.73 Million TWD	4.11%
2022 Q1	188.02 Million TWD	38.49%
2022 Q4	225.76 Million TWD	-25.88%
2022 Q3	304.58 Million TWD	67.95%
2021 Q1	323.62 Million TWD	-35.03%
2021 Q3	228.25 Million TWD	29.27%
2021 Q2	176.57 Million TWD	-45.44%
2021 FY	864.21 Million TWD	-67.86%
2021 Q4	135.76 Million TWD	-40.52%
2020 FY	2.68 Billion TWD	14.16%
2020 Q2	727.92 Million TWD	-7.19%
2020 Q3	678.83 Million TWD	-6.74%
2020 Q4	498.13 Million TWD	-26.62%
2020 Q1	784.32 Million TWD	50.84%
2019 Q1	603.68 Million TWD	29.99%
2019 Q4	519.95 Million TWD	-17.18%
2019 FY	2.35 Billion TWD	21.44%
2019 Q3	627.81 Million TWD	3.89%
2019 Q2	604.28 Million TWD	0.1%
2018 Q3	519.41 Million TWD	-2.08%
2018 FY	1.93 Billion TWD	49.1%
2018 Q4	464.41 Million TWD	-10.59%
2018 Q2	530.43 Million TWD	24.62%
2018 Q1	425.64 Million TWD	27.75%
2017 Q4	333.17 Million TWD	-6.16%
2017 FY	1.3 Billion TWD	-31.64%
2017 Q1	328.54 Million TWD	27.18%
2017 Q2	284.27 Million TWD	-13.48%
2017 Q3	355.05 Million TWD	24.9%
2016 Q1	645.47 Million TWD	84.8%
2016 Q3	476.68 Million TWD	-8.79%
2016 Q4	258.33 Million TWD	-45.81%
2016 FY	1.9 Billion TWD	5.11%
2016 Q2	522.6 Million TWD	-19.04%
2015 Q1	443.06 Million TWD	32.87%
2015 Q2	579.64 Million TWD	30.83%
2015 FY	1.81 Billion TWD	21.36%
2015 Q3	438.5 Million TWD	-24.35%
2015 Q4	349.28 Million TWD	-20.35%
2014 Q2	416.44 Million TWD	11.18%
2014 Q4	333.46 Million TWD	-9.23%
2014 FY	1.49 Billion TWD	15.4%
2014 Q1	374.57 Million TWD	24.08%
2014 Q3	367.38 Million TWD	-11.78%
2013 FY	1.29 Billion TWD	2.39%
2013 Q3	346.83 Million TWD	12.94%
2013 Q4	301.88 Million TWD	-12.96%
2013 Q2	307.09 Million TWD	-8.85%
2013 Q1	336.92 Million TWD	8.91%
2012 Q2	281.66 Million TWD	-21.4%
2012 Q1	358.34 Million TWD	31.93%
2012 Q4	309.34 Million TWD	-1.24%
2012 Q3	313.21 Million TWD	11.2%
2012 FY	1.26 Billion TWD	21.65%
2011 Q3	252.55 Million TWD	2.17%
2011 Q1	266.49 Million TWD	-3.49%
2011 Q2	247.19 Million TWD	-7.24%
2011 FY	1.03 Billion TWD	4.34%
2011 Q4	271.6 Million TWD	7.54%
2010 FY	994.67 Million TWD	9.82%
2010 Q2	239.56 Million TWD	4.15%
2010 Q1	230.01 Million TWD	0.0%
2010 Q4	276.14 Million TWD	10.92%
2010 Q3	248.95 Million TWD	3.92%
2009 FY	905.73 Million TWD	0.0%

Peer Revenue Comparison of SCI Pharmtech, Inc.

Name	Revenue	Revenue Difference
Grape King Bio Ltd	10.63 Billion TWD	88.675%
Standard Chem & Pharm CO., LTD.	6.23 Billion TWD	80.702%
Maywufa Company Ltd.	1.3 Billion TWD	7.424%
ScinoPharm Taiwan, Ltd.	3.18 Billion TWD	62.206%
Lotus Pharmaceutical Co., Ltd.	16.95 Billion TWD	92.899%
LIWANLI Innovation Co., Ltd.	38.88 Million TWD	-2996.559%
YungShin Global Holding Corporation	7.02 Billion TWD	82.866%
PhytoHealth Corporation	162.48 Million TWD	-641.071%
Formosa Laboratories, Inc.	4.36 Billion TWD	72.385%
PharmaEssentia Corporation	5.1 Billion TWD	76.415%
Bora Pharmaceuticals Co., LTD.	14.2 Billion TWD	91.52%

Global Stocks Search

SCI Pharmtech, Inc. (4119.TW)

Revenue Summary of SCI Pharmtech, Inc.

Annual Revenue Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Revenue of SCI Pharmtech, Inc. (2023 - 2009)

Peer Revenue Comparison of SCI Pharmtech, Inc.